Terms: = Kidney tumors AND RUNX1T1, ENSG00000079102, 862 AND Treatment
10 results:
1. Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.
Oosterom N; Gooskens SLM; Renfro LA; Perlman EJ; van den Heuvel-Eibrink MM; Hamilton TE; Green DM; Grundy PE; Daw NC; Geller JI; Dome JS; Fernandez CV; Mullen EA
J Clin Oncol; 2023 Sep; 41(26):4247-4256. PubMed ID: 37343199
[TBL] [Abstract] [Full Text] [Related]
2. Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study.
Zheng J; Li S; Zhao Y; Tao Z; Li L; Li Z; Li M; Chen X
BMJ Open; 2022 Sep; 12(9):e062129. PubMed ID: 36581979
[TBL] [Abstract] [Full Text] [Related]
3. Using machine learning for mortality prediction and risk stratification in atezolizumab-treated cancer patients: Integrative analysis of eight clinical trials.
Wu Y; Zhu W; Wang J; Liu L; Zhang W; Wang Y; Shi J; Xia J; Gu Y; Qian Q; Hong Y
Cancer Med; 2023 Feb; 12(3):3744-3757. PubMed ID: 35871390
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis.
Mori K; Janisch F; Mostafaei H; Lysenko I; Kimura S; Egawa S; Shariat SF
Urol Oncol; 2020 May; 38(5):315-333. PubMed ID: 32088103
[TBL] [Abstract] [Full Text] [Related]
5. Use of Inpatient Palliative Care Services in Patients With Advanced Cancer Receiving Critical Care Therapies.
Loh KP; Abdallah M; Shieh MS; Stefan MS; Pekow PS; Lindenauer PK; Mohile SG; Babu D; Lagu T
J Natl Compr Canc Netw; 2018 Sep; 16(9):1055-1064. PubMed ID: 30181417
[No Abstract] [Full Text] [Related]
6. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032
[TBL] [Abstract] [Full Text] [Related]
7. EAU guidelines on renal cell carcinoma: 2014 update.
Ljungberg B; Bensalah K; Canfield S; Dabestani S; Hofmann F; Hora M; Kuczyk MA; Lam T; Marconi L; Merseburger AS; Mulders P; Powles T; Staehler M; Volpe A; Bex A
Eur Urol; 2015 May; 67(5):913-24. PubMed ID: 25616710
[TBL] [Abstract] [Full Text] [Related]
8. Potential clinical applications of epothilones: a review of phase II studies.
Larkin JM; Kaye SB
Ann Oncol; 2007 Jul; 18 Suppl 5():v28-34. PubMed ID: 17656559
[TBL] [Abstract] [Full Text] [Related]
9. Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors.
Busca A; Novarino A; de Fabritiis P; Picardi A; Zeuli M; Locatelli F; Bertetto O; Falda M
Hematology; 2006 Jun; 11(3):171-7. PubMed ID: 17325957
[TBL] [Abstract] [Full Text] [Related]
10. [X-ray intravascular surgery in oncologic urology].
Granov AM; Karelin MI; Tarazov PG; Shkol'nik MI; Shumskiĭ IA; Polikarpov AA; Suvorova IuV; Shmonina LS
Vestn Rentgenol Radiol; 1996; (1):35-7. PubMed ID: 8644468
[TBL] [Abstract] [Full Text] [Related]